• OncoZenge drew a SEK 2 million bridge loan from John Haurum to cover liquidity needs pending a SEK 33.3 million rights issue.
• Loan disbursed today; carries a 5% arrangement fee, interest of 1.5% per month.
• Lender can request set-off into a directed share issue at the rights issue subscription price; board retains discretion to proceed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncozenge AB published the original content used to generate this news brief on August 28, 2026, and is solely responsible for the information contained therein.